2015 FCA Paper 2 Flashcards
a) Discuss
a) the pros and cons and
b) possible evidence or controversies regarding outcomes or efficacy of the following analgesic techniques for post-thoracotomy pain relief.
i) Thoracic epidural analgesia (TEA). (13)
ii) Paravertebral block (PVB). (13)
iii) Continuous wound infiltration (CWI). (4)
(The above abbreviations are acceptable in your answer)
In a systematic review by the Procedure Specific Postoperative Pain Management working group (PROSPECT), paravertebral and thoracic epidural continuous infusions of opioid-free local anaestheticwerefoundtobecomparable,butPVAwasassociated with less respiratory complications and hypotension.10 Furthermore, in a Cochrane Review by the authors, PVB was found to be associated with lower rate of major complications including chest infection and acute confusion and minor complications such as low blood pressure, nausea and vomiting, itching and urinary retention when compared to TEA.11 A single bolus of intrathecal opioidbeforeoperationwasalsocomparablewithbothtechniques. However, the duration of analgesia was limited to 24 h.10 Based on the review, PROSPECT recommend that either TEA with local anaesthetics and an opioid or continuous PVA with local anaesthetics combined with parenteral paracetamol and an NSAIDshould beusedasfirst-line analgesia for thoracotomy. Wherethese techniques arenot possible, or are contraindicated, intrathecal opioid or intercostal nerve block are recommended, which requires the use of supplementary systemic analgesia. The PROSPECT recommendations are summarized in Figure 4. Although VATS is associated with less acute pain than open thoracotomy, it may still be significant if intercostal nerves are compressed by twisting instruments and the need for an incision to extract lobes.Ifthepatienthaspoorrespiratoryreserveortheir disease increases the likelihood of conversion to thoracotomy, TEA is advisable. Otherwise, the combination of PVA with i.v. PCA is a suitable alternative.Whenneuraxial analgesia is not feasible, intercostal nerve block coupled with systemic parenteral analgesia remains an option. The block is simple to perform either percutaneously or under direct vision intraoperatively. However, its limited durationofaction (∼6 h) necessitates repeating the block at multiple levels or starting an infusion. This increases the risk of systemic toxicity from the highly vascular intercostal space. Incomplete analgesia is also aproblemsincethedorsalramisupplyingthebackarenot blocked, which is relevant in posterolateral thoracotomies, and the lateral cutaneous branch may also be missed if the block is performed too anteriorly. Intrapleural analgesia, where local anaesthetics are injected between the layers of the parietal and visceral pleura, is not recommended. Surgery increases the volume of the interpleural space with blood and air which dilutes the spread of local anaesthetics. Systemic absorption of local anaesthetics is also considerable.
b) Discuss the factors that impair hypoxic pulmonary vasoconstriction in the non-ventilated lung during one lung ventilation. (20)
[50]
HYPOXIC pulmonary vasoconstriction (HPV) is a reflex contraction of vascular smooth muscle in the pulmonary circulation in response to low regional partial pressure of oxygen (Po2). This vasoconstriction by the pulmonary vasculature represents its fundamental difference from the systemic circulation, which typically vasodilates in response to hypoxia.
1. Position
2. Drugs
• Induction agents
• Volatiles
•
3. Inadequate lung collapse
4. Acid base status pulmonary vasculature vasoconstricts in response to acidosis and dilates during alkalosis
5. Cardiac output Hypoxic pulmonary vasoconstriction will tend to decrease if cardiac output increases and PAPs increase. Also, as cardiac output increases mixed venous oxygen saturation will usually increase and this will also diminish HPV
A 1-day-old, 3.3kg neonate, is presented to you, by the paediatric surgeon, for the repair of a
tracheo-oesophageal fistula (TOF). The patient was born at 38 weeks gestation by normal vaginal delivery.
a) What is the typical presentation of a patient with a tracheo-oesophageal fistula? (10)
seen in 1: 3000 – 4500 live births
involving multiple genes
and complex gene-environment interaction
Respiratory insufficiency, however is the single most
significant risk factor affecting outcome.
Associated anomalies include:
- cardiac (29%) ASD, VSD or Tetralogy of Fallot (presence of major cardiac anomaly reduces an almost
complete survival rate to around 80%)
- duodenal atresia and anorectal (14%)
- genitourinary (14%)
- intestinal malrotation (13%)
- chromosomal abnormalities (trisomy 21, 18, 13q deletion)
- vertebral and skeletal anomalies (10%)
- specific associations (VATER/VACTERL, CHARGE syndrome, Potters syndrome and Schisis association
Suspicion can be raised by antenatal ultrasound which shows an absent or small gastric bubble. A history of
polyhydramnios should prompt the passing of a size 8 – 10 F orogastric tube in the baby soon after delivery. This is
then confirmed by a plain chest and abdominal X-ray. Other anomalies such as vertebral anomalies or ‘double
bubble’ of duodenal atresia can also be detected on preoperative films.
Within a few hours of birth the infant will present frothy, unable to swallow secretions and they may have choking
or cyanotic spells. The development of aspiration pneumonia is a delayed diagnosis. An echocardiogram is highly
recommended prior to surgery and if the child has passed urine a renal US can be delayed until after surgery.
1-day-old, 3.3kg neonate, is presented to you, by the paediatric surgeon, for the repair of a
tracheo-oesophageal fistula (TOF). The patient was born at 38 weeks gestation by normal
vaginal delivery.
b) Discuss your pre-operative assessment and perioperative management of this patient.
○ Initial management is to prevent aspiration, so a 8 – 10 F double lumen oro-oesophageal Reploge tube (perforations along the side of the catheter are located only near the tip, which minimises the possibility of suctioning oxygenated air away from the larynx) is inserted into the upper pouch and placed on continous suction or secretions cleared by
regular NGT suction.
○ Maintenance fluid is given, the child nursed at 30˚ head up or on its side.
○ An oesophagoscpy or bronchoscopy is usually performed at the start of surgery to provide absolute confirmation of the position of the defect, then the anticipated surgical approach is extrapleural via a right posterolateral thoracotomy.
○ If a right aortic arch is confirmed on pre-op echo, a left sided approach may be considered.
○ Major concerns about surgery (including
thoracoscopic approach) include accurate identification of anatomical structures and cardiorespiratory instability
due to possible OLV and the distortion of the trachea.
A 26-year-old primigravida at 34 weeks gestation is admitted to the labour ward. Her admission
BP is 170/110 mmHg. She complains of headache and epigastric pain
Define severe preeclampsia, and indicate the relevant diagnostic criteria. (5)
Preeclampsia is defined as hypertension occurring after 20-week gestation with SBP >130 DBP >90 mmhg.
Severe preeclampsia is no longer acceptable term it is now referred to preeclampsia with severe features which include
○ Severe hypertension >160/110
○ CNS involvement
○ Pulmonary oedema
○HELLP syndrome
○ Renal impairment
What are the organ system effects associated with, and important considerations in the management of severe preeclampsia?
Neuro: neuroprotection, risk of seizure, can. Low Mac and anesthetic, prolonged nmb duration requirements mgso4
Airway : oedema, friable tissues, difficult airway trolley small ett requied
Cardiac : lvd, cardiomyopathy
Respiratory : Low frc, basal atelectasis, v/q mismatch, high airway pressures
Renal : glomerular damage proteinuria,
Hepatic : coagulopathy, Low pseudocholinastarase,
Discuss the anaesthetic management of this patient if she presents in pulmonary oedema for caesarean delivery for a non-reassuring fetal heart trace. (30)
Question 1
Glutamine supplementation to critically ill patients:
a) What is glutamine, and why should glutamine supplementation been given to critically ill adult and
paediatric patients. What is the rationale for the choice of route of administration? (9)
Glutamine supplementation to critically ill patients:
b) What are the potential problems/disadvantages associated with glutamine supplementation?
(3)
Tetanus:
a) What is the causative organism of tetanus, and what are the cardiovascular
complications?
(4)
Tetanus:
b) Name the drugs used to manage the deranged haemodynamics in patients with tetanus, and state the mechanism of action of each. (8)
Question 3
Lactate:
a) Where in the body is lactate produced, and what is the most common mechanism of
hyperlactataemia?
b) Name other causes of a raised lactate level, and state their mechanism(s). (9)
Question 4
Goal-directed fluid therapy (GDFT):
a) Give a definition of “Goal-directed fluid therapy”, and state how fluids are given when applying this
approach. (4)
Goal-directed fluid therapy (GDFT):
b) What are dynamic predictors of fluid responsiveness and what do they identify? (10)
Question 5
With reference to the use of patient controlled analgesia (PCA) after a laparotomy:
a) What are the potential complications of PCA and how are these avoided? (4)
b) Write a prescription for a PCA management plan, exactly as you would in clinical practice. Include
instructions to nursing staff as you feel appropriate. (10)
Question 6
With reference to intravenous paracetamol:
a) Describe the contents of a 1g vial of intravenous paracetamol. What side-effects and precautions
relate to the contents other than that of paracetamol? (4)
b) What limitations are there on the dosage and administration of intravenous paracetamol for adult
patients in terms of current South African registration? (3
c) What is the specific toxic metabolite of paracetamol, and what are the potential side effects
associated with the administration of intravenous paracetamol? (4)
Question 7
With respect to the stellate ganglion:
a) What is the stellate ganglion and what are the potential indications for stellate ganglion block? (5)
b) What are all the clinical signs that immediately confirm successful stellate ganglion block, and what are the potential complications? (9)
Question 8
With regard to complex regional pain syndrome (CRPS):
a) Describe the principal clinical components of CRPS, and give an example of each. (8)
b) What is the difference between sympathetically maintained pain and sympathetically independent
pain? (3)
Question 9
List the airway implications of long-standing acromegaly, and briefly describe how you would plan your
anaesthetic to provide safe management of these issues. [15]
Question 10
Briefly describe the advantages and disadvantages of “tight” glucose control during major surgery and
critical care. [20]
Question 11
What are the potential consequences of chronic steroid usage (30 mg prednisone daily), and how would
you manage perioperative steroid administration in such a patient? [15]
Question 12
Briefly describe the pathophysiology of trauma-associated coagulopathy. [20]
Question 13
What are the clinical applications and evidence for the use of antifibrinolytics in the setting of trauma-
associated coagulopathy? [15]
Question 14
Write short notes on the prevention and treatment of fat embolism. [15]
You are responding to a rural hospital consult on a patient with severe Acute Respiratory
Distress Syndrome (ARDS) for possible transfer and admission into your unit
a) i) Give a comprehensive definition of Acute Respiratory Distress Syndrome (ARDS) based on the Berlin Definition.
ii) How is the severity of ARDS graded? (6)
b) After intubating the patient, what further advice would you give to the referring hospital on ventilatory optimisation before accepting the patient? (14)
What are the advanced and non-conventional methods of ventilation available for ARDS and what are the challenges with each of them? (12)
c) What are the advanced and non-conventional methods of ventilation available for ARDS and what are the challenges with each of them? (12)
i) What are the challenges and controversies of ECMO (extra-corporeal membrane oxygenation) usage in the South African context? (5)
ii) What are appropriate guidelines for patient consideration and definite selection for
ECMO? (5)